RIFAMPICIN, powder, 1 g [Sigma-R3501-1G]
STD
SASTAPWDRIF1
Valid Article
Account code:
60200
HS Code:
382290
Last Updated on:
12/04/2024, 17:24:52
Former
Code(s):
SLASRIFA1P-
Single use
A single-use device, also referred to as a disposable device, is intended for use on one patient during a single procedure. It is not intended to be reprocessed (i.e., cleaned and disinfected or sterilized).
W0104010699 - Media for mycobacteria cultures - manual & automated (for ast drugs , supplements) - other
European Medical Device Nomenclature (EMDN) is the nomenclature of use by manufacturers when registering their medical devices in the EUDAMED database. EMDN is characterised by its alphanumeric structure that is established in a seven-level hierarchical tree.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
RIFAMPICIN
Reserved for TB culture programmes.
Definition
Antimycobacterial used for drug susceptibility testing of M. tuberculosis complex.
Synonym: 3-(4-Methylpiperazinyliminomethyl)rifamycin SV, Rifampin, Rifamycin AMP.
Specifications
Some restricted information has been hidden. Sign in
to see this information
Technical specifications
- Crystalline red powder
- Easily soluble in methyl chloride, dimethyl sulfoxyde and chloroform, soluble in ethyl acetate and in methanol. Slightly soluble in water (pH less than 6)
- Formula: C43H58N4O12
- Purity: 97%
Packaging & Labelling
1 g in glass vial
Transport not regulated
Instructions for use
For the procedure of stock solution and working solution preparations, refer to Tuberculosis Culture Laboratory, MSF-ITM, 2014.
Storage
- Recommended storage temperature -20°C
- Store in tight, light-resistant container
Classification EC Regulation N° 1272/2008
- Acute toxicity, Oral : Category 4
- Skin irritation : Category 2
Signal Word
Warning
H302 | Harmful if swallowed |
H315 | Causes skin irritation |
H319 | Causes serious eye irritation |
H335 | May cause respiratory irritation |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P305 + P351 + P338 | IF IN EYES: rinse cautiously with water for several minutes. If the victim wears contact lenses, remove them if possible. Keep rinsing |
MSF requirements
Rifampicin is the key antibiotic of the first line drugs used against M. tuberculosis complex. The test is performed to investigate resistance of the mycobacterium to this antibiotic. The drug solution is added to agar or egg-based media during preparation.
Some restricted information has been hidden. Sign in
to see this information
Some restricted information has been hidden. Sign in
to see this information